36 research outputs found
Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression
Angiogenesis involves the formation of new blood vessels by sprouting or
splitting of existing blood vessels. During sprouting, a highly motile type of
endothelial cell, called the tip cell, migrates from the blood vessels followed
by stalk cells, an endothelial cell type that forms the body of the sprout. To
get more insight into how tip cells contribute to angiogenesis, we extended an
existing computational model of vascular network formation based on the
cellular Potts model with tip and stalk differentiation, without making a
priori assumptions about the differences between tip cells and stalk cells. To
predict potential differences, we looked for parameter values that make tip
cells (a) move to the sprout tip, and (b) change the morphology of the
angiogenic networks. The screening predicted that if tip cells respond less
effectively to an endothelial chemoattractant than stalk cells, they move to
the tips of the sprouts, which impacts the morphology of the networks. A
comparison of this model prediction with genes expressed differentially in tip
and stalk cells revealed that the endothelial chemoattractant Apelin and its
receptor APJ may match the model prediction. To test the model prediction we
inhibited Apelin signaling in our model and in an \emph{in vitro} model of
angiogenic sprouting, and found that in both cases inhibition of Apelin or of
its receptor APJ reduces sprouting. Based on the prediction of the
computational model, we propose that the differential expression of Apelin and
APJ yields a "self-generated" gradient mechanisms that accelerates the
extension of the sprout.Comment: 48 pages, 10 figures, 8 supplementary figures. Accepted for
publication in PLoS ON
Tip Cells in Angiogenesis
In angiogenesis, the process in which blood vessel sprouts grow out from a pre-existing vascular network, the so-called endothelial tip cells play an essential role. Tip cells are the leading cells of the sprouts; they guide following endothelial cells and sense their environment for guidance cues. Because of this essential role, the tip cells are a potential therapeutic target for anti-angiogenic therapies, which need to be developed for diseases such as cancer and major eye diseases. The potential of anti-tip cell therapies is now widely recognised, and the surge in research this has caused has led to improved insights in the function and regulation of tip cells, as well as the development of novel in vitro and in silico models. These new models in particular will help understand essential mechanisms in tip cell biology and may eventually lead to new or improved therapies to prevent blindness or cancer spread
Computational screening of angiogenesis model variants predicts that differential chemotaxis helps tip cells move to the sprout tip and accelerates sprouting
Computational screening of tip and stalk cell behavior proposes a role for apelin signaling in sprout progression
Angiogenesis involves the formation of new blood vessels by sprouting or splitting of existing blood vessels. During sprouting, a highly motile type of endothelial cell, called the tip cell, migrates from the blood vessels followed by stalk cells, an endothelial cell type that forms the body of the sprout. To get more insight into how tip cells contribute to angiogenesis, we extended an existing computational model of vascular network formation based on the cellular Potts model with tip and stalk differentiation, without making a priori assumptions about the differences between tip cells and stalk cells. To predict potential differences, we looked for parameter values that make tip cells (a) move to the sprout tip, and (b) change the morphology of the angiogenic networks. The screening predicted that if tip cells respond less effectively to an endothelial chemoattractant than stalk cells, they move to the tips of the sprouts, which impacts the morphology of the networks. A comparison of this model prediction with genes expressed differentially in tip and stalk cells revealed that the endothelial chemoattractant Apelin and its receptor APJ may match the model prediction. To test the model prediction we inhibited Apelin signaling in our model and in an in vitro model of angiogenic sprouting, and found that in both cases inhibition of Apelin or of its receptor APJ reduces sprouting. Based on the prediction of the computational model, we propose that the differential expression of Apelin and APJ yields a "self-generated" gradient mechanisms that accelerates the extension of the sprout
Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
Photographs of HMEC-1 spheroids. Part of article "Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression”
Computational screening of angiogenesis model variants predicts that differential chemotaxis helps tip cells move to the sprout tip and accelerates sprouting
Moraxella nonliquefaciens-associated infectious scleritis
Infectious scleritis is a rare disease entity with potentially devastating visual sequelae. Here we present the clinical history, work-up and aetiology of an unusual case of infectious scleritis. </p
The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro
During angiogenesis, vascular endothelial growth factor A (VEGFA) regulates endothelial cell (EC) survival, tip cell formation, and stalk cell proliferation via VEGF receptor 2 (VEGFR2). VEGFR2 can interact with VEGFR2 co-receptors such as heparan sulfate proteoglycans (HSPGs) and neuropilin 2 (NRP2), but the exact roles of these co-receptors, or of sulfatase 2 (SULF2), an enzyme that removes sulfate groups from HSPGs and inhibits HSPG-mediated uptake of very low density lipoprotein (VLDL), in angiogenesis and tip cell biology are unknown. In the present study, we investigated whether the modulation of binding of VEGFA to VEGFR2 by knockdown of SULF2 or NRP2 affects sprouting angiogenesis, tip cell formation, proliferation of non-tip cells, and EC survival, or uptake of VLDL. To this end, we employed VEGFA splice variant 121, which lacks an HSPG binding domain, and VEGFA splice variant 165, which does have this domain, in in vitro models of angiogenic tip cells and vascular sprouting. We conclude that VEGFA165 and VEGFA121 have similar inducing effects on tip cells and sprouting in vitro, and that the binding of VEGFA165 to HSPGs in the extracellular matrix does not seem to play a role, as knockdown of SULF2 did not alter these effects. Co-binding of NRP2 appears to regulate VEGFA–VEGFR2-induced sprout initiation, but not tip cell formation. Finally, as the addition of VLDL increased sprout formation but not tip cell formation, and as VLDL uptake was limited to non-tip cells, our findings suggest that VLDL plays a role in sprout formation by providing biomass for stalk cell proliferation
The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro
During angiogenesis, vascular endothelial growth factor A (VEGFA) regulates endothelial cell (EC) survival, tip cell formation, and stalk cell proliferation via VEGF receptor 2 (VEGFR2). VEGFR2 can interact with VEGFR2 co-receptors such as heparan sulfate proteoglycans (HSPGs) and neuropilin 2 (NRP2), but the exact roles of these co-receptors, or of sulfatase 2 (SULF2), an enzyme that removes sulfate groups from HSPGs and inhibits HSPG-mediated uptake of very low density lipoprotein (VLDL), in angiogenesis and tip cell biology are unknown. In the present study, we investigated whether the modulation of binding of VEGFA to VEGFR2 by knockdown of SULF2 or NRP2 affects sprouting angiogenesis, tip cell formation, proliferation of non-tip cells, and EC survival, or uptake of VLDL. To this end, we employed VEGFA splice variant 121, which lacks an HSPG binding domain, and VEGFA splice variant 165, which does have this domain, in in vitro models of angiogenic tip cells and vascular sprouting. We conclude that VEGFA165 and VEGFA121 have similar inducing effects on tip cells and sprouting in vitro, and that the binding of VEGFA165 to HSPGs in the extracellular matrix does not seem to play a role, as knockdown of SULF2 did not alter these effects. Co-binding of NRP2 appears to regulate VEGFA-VEGFR2-induced sprout initiation, but not tip cell formation. Finally, as the addition of VLDL increased sprout formation but not tip cell formation, and as VLDL uptake was limited to non-tip cells, our findings suggest that VLDL plays a role in sprout formation by providing biomass for stalk cell proliferation